124 related articles for article (PubMed ID: 21821528)
1. Is it time to translate ischemic preconditioning's mechanism of cardioprotection into clinical practice?
Cohen MV; Downey JM
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):273-80. PubMed ID: 21821528
[TBL] [Abstract][Full Text] [Related]
2. Realizing the clinical potential of ischemic preconditioning and postconditioning.
Yellon DM; Hausenloy DJ
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
[TBL] [Abstract][Full Text] [Related]
3. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
[TBL] [Abstract][Full Text] [Related]
4. Clinical efforts to reduce myocardial infarct size--the next step.
Braunwald E
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection in heart surgery.
Mentzer RM
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):290-7. PubMed ID: 21821531
[TBL] [Abstract][Full Text] [Related]
7. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
8. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
9. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
10. Myocardial protection at a crossroads: the need for translation into clinical therapy.
Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning and postconditioning: new strategies for cardioprotection.
Hausenloy DJ; Yellon DM
Diabetes Obes Metab; 2008 Jun; 10(6):451-9. PubMed ID: 17825079
[TBL] [Abstract][Full Text] [Related]
12. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
Lecour S; Suleman N; Deuchar GA; Somers S; Lacerda L; Huisamen B; Opie LH
Circulation; 2005 Dec; 112(25):3911-8. PubMed ID: 16344382
[TBL] [Abstract][Full Text] [Related]
14. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
Vinten-Johansen J; Shi W
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of infarction in cynomolgus monkeys: preconditioning and postconditioning.
Yang XM; Liu Y; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
Basic Res Cardiol; 2010 Jan; 105(1):119-28. PubMed ID: 19669077
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion.
Fan MH; Wong KL; Wu S; Leung WK; Yam WC; Wong TM
J Periodontal Res; 2010 Feb; 45(1):100-8. PubMed ID: 19602110
[TBL] [Abstract][Full Text] [Related]
17. Activation of central opioid receptors induces cardioprotection against ischemia-reperfusion injury.
Wong GT; Ling Ling J; Irwin MG
Anesth Analg; 2010 Jul; 111(1):24-8. PubMed ID: 19861363
[TBL] [Abstract][Full Text] [Related]
18. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
[TBL] [Abstract][Full Text] [Related]
19. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
Canyon SJ; Dobson GP
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
